Showing latest transactions and SEC Form 4 filings for OBIO.
7 results.
| X | Filing Date | Trade Date | Ticker | Company Name | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 16:27:37 | 2026-11-09 | OBIO | Orchestra BioMed Holdings, Inc. | RTW INVESTMENTS, LP | 10% Owner | P - Purchase | $5.00 | +1,200,000 | 10,756,063 | +13% | +$6,000,000 | |
| 2026-11-09 16:32:17 | 2026-11-09 | OBIO | Orchestra BioMed Holdings, Inc. | Fain Eric S | Director | P - Purchase | $5.00 | +20,000 | 119,630 | +20% | +$100,000 | |
| 2026-11-09 16:31:40 | 2026-11-09 | OBIO | Orchestra BioMed Holdings, Inc. | Pacitti David | Director | P - Purchase | $5.00 | +20,000 | 74,750 | +37% | +$100,000 | |
| 2026-11-09 16:31:08 | 2026-11-09 | OBIO | Orchestra BioMed Holdings, Inc. | Hochman David P | See Remarks, Director | P - Purchase | $5.00 | +5,000 | 1,514,519 | +0% | +$25,000 | |
| 2026-11-09 16:30:17 | 2026-11-09 | OBIO | Orchestra BioMed Holdings, Inc. | Taylor Andrew Lawrence | Chief Financial Officer | P - Purchase | $5.00 | +1,000 | 590,989 | +0% | +$5,000 | |
| 2026-11-03 17:14:38 | 2026-11-02 | OBIO | Orchestra BioMed Holdings, Inc. | Sherman Darren | See Remarks, Director | S - Sale | $5.74 | -15,000 | 1,106,402 | -1% | -$86,100 | |
| 2026-10-02 16:30:51 | 2026-10-01 | OBIO | Orchestra BioMed Holdings, Inc. | Sherman Darren | See Remarks, Director | S - Sale | $6.36 | -15,000 | 1,121,402 | -1% | -$95,400 |